IDO1 and neoplasm: There are also metabolic inhibitors including IDO and arginase, which are produced by tumor associated macrophages (particularly the M2 phenotype) and upregulation of receptors such as CTLA4 and PD-1, all of which may be contributing to tumor immune escape [45,46].